Skip to content
PatentBrief
Get alertsTop ↑

How Medical Monitors Adapt Oxygen Alarms to Reduce False Alerts

This patent describes an adaptive alarm system for medical patient monitors that dynamically adjusts oxygen saturation thresholds based on recent patient data, aiming to reduce unnecessary alerts.

Granted 2019ActiveExpires 2038Owned by Masimo CorpInvented by Ammar Al-Ali

Original patent title: “USRE47218E1 - Adaptive alarm system

Plain-English explanation by SahiLast reviewed · June 15, 2026

This patent describes an adaptive alarm system for medical patient monitors that dynamically adjusts oxygen saturation thresholds based on recent patient data, aiming to reduce unnecessary alerts. Granted to Masimo Corp in 2019 with 21 claims and 251 forward citations.

Key facts

Patent numberUS RE47218
StatusActive
FieldBiotech & Medicine
AssigneeMasimo Corp
InventorAmmar Al-Ali
Filed2018
Granted2019
Claims21
Times cited251
LitigationNone on record
Value · $1.1M$3.4MHigh value

Coverage

What does this patent actually cover?

This system reduces false alarms in medical patient monitoring by intelligently adjusting oxygen saturation (SpO2) thresholds. It uses an optical sensor to measure a patient's SpO2 values over a first period of time. If these values exceed a first alarm threshold, the system then calculates a new, second alarm threshold for a subsequent period. This second threshold is determined by comparing the patient's current SpO2 to a predefined lower limit. Crucially, the system computes this second threshold with an "offset" from the measured SpO2 value, and this offset shrinks as the patient's SpO2 gets closer to the dangerous lower limit (ClaimclaimA numbered sentence at the end of a patent that legally defines what the inventor owns. The most important section.Read more → 1). This means the alarm becomes more sensitive when oxygen levels are already low. For example, if a patient's SpO2 is stable at 95%, the system might set a new, slightly lower alarm threshold of 90%. If the SpO2 then drops to 88%, an alarm would trigger.

The gap

What does this patent NOT cover?

  • Does not cover alarm systems that use fixed, unchanging thresholds for oxygen saturation, regardless of the patient's current stable levels.
  • Does not cover adaptive alarm systems for other vital signs, such as heart rate or blood pressure, if they do not use the specific SpO2 threshold adaptation method described.
  • Does not cover systems where the alarm threshold is adjusted based on a patient's long-term historical data or general population statistics, rather than recent, specific measurements.
  • Does not cover alarm systems where the 'offset' for the new threshold does not diminish as the patient's oxygen level gets closer to a dangerous lower limit (ClaimclaimA numbered sentence at the end of a patent that legally defines what the inventor owns. The most important section.Read more → 1).
  • Does not cover systems that adapt thresholds based solely on trends or rates of change in oxygen saturation, without the specific comparison to a lower limit and diminishing offset.

These exclusions are unique to PatentBrief — derived from the actual claim language, not patent-office boilerplate.

What made this novel

The clever part is how the system dynamically adjusts the alarm threshold based on recent patient data and a diminishing offset. As a patient's oxygen saturation approaches a critical lower limit, the alarm threshold becomes tighter, making the system more sensitive when it matters most, without triggering false alarms during stable periods.

USRE47218E1 - Adaptive alarm s…(Primary claim)medical devicesconsumer electronicstelecommunicationssoftware

Schematic visualization of the patent's claim structure. Hand-drawn diagrams in progress for each landmark patent.

Where you've seen this

Real-world examples

01

Masimo pulse oximeters

02

Hospital patient monitoring systems

03

Wearable medical sensors for continuous SpO2 tracking

04

Home health monitoring devices for respiratory conditions

Why it matters

The bigger picture

In hospitals, too many false alarms can lead to "alarm fatigue," where medical staff become desensitized to alerts, potentially missing real emergencies. This patent addresses this critical issue by making patient monitoring systems smarter and more responsive to individual patient conditions. By reducing unnecessary alarms, it helps ensure that healthcare providers focus on truly critical events, improving patient safety and staff efficiency.

Filed

January 26, 2018

Granted

February 5, 2019

Market context

Who's building on this

Companies in this space

Masimo Corp, the original assigneeassigneeThe entity that owns the patent — usually the inventor's employer or a company.Read more →, is a leading company in noninvasive patient monitoring, particularly known for its pulse oximetry technology. They continue to develop and integrate advanced alarm management into their patient monitoring platforms. Other major medical device manufacturers in the patient monitoring space, such as Philips and GE Healthcare, also invest heavily in smart alarm technologies to combat alarm fatigue.

Market impact

This patent contributes to the ongoing effort to combat alarm fatigue in healthcare settings, a significant problem that can compromise patient safety and staff well-being. By enabling more intelligent and context-aware alarm systems, it helps differentiate patient monitoring products. The technology allows for more personalized patient care by tailoring alarm thresholds to individual patient baselines, which can lead to better clinical outcomes and more efficient use of medical resources.

Claim 1 — Plain English

What this patent covers

This system reduces false alarms in medical patient monitoring by intelligently adjusting oxygen saturation (SpO2) thresholds. It uses an optical sensor to measure a patient's SpO2 values over a first period of time. If these values exceed a first alarm threshold, the system then calculates a new, second alarm threshold for a subsequent period. This second threshold is determined by comparing the patient's current SpO2 to a predefined lower limit. Crucially, the system computes this second threshold with an "offset" from the measured SpO2 value, and this offset shrinks as the patient's SpO2 gets closer to the dangerous lower limit (Claim 1). This means the alarm becomes more sensitive when oxygen levels are already low. For example, if a patient's SpO2 is stable at 95%, the system might set a new, slightly lower alarm threshold of 90%. If the SpO2 then drops to 88%, an alarm would trigger.

The clever bit

The clever part is how the system dynamically adjusts the alarm threshold based on recent patient data and a diminishing offset. As a patient's oxygen saturation approaches a critical lower limit, the alarm threshold becomes tighter, making the system more sensitive when it matters most, without triggering false alarms during stable periods.

What it does not cover

  • Does not cover alarm systems that use fixed, unchanging thresholds for oxygen saturation, regardless of the patient's current stable levels.
  • Does not cover adaptive alarm systems for other vital signs, such as heart rate or blood pressure, if they do not use the specific SpO2 threshold adaptation method described.
  • Does not cover systems where the alarm threshold is adjusted based on a patient's long-term historical data or general population statistics, rather than recent, specific measurements.
  • Does not cover alarm systems where the 'offset' for the new threshold does not diminish as the patient's oxygen level gets closer to a dangerous lower limit (Claim 1).
  • Does not cover systems that adapt thresholds based solely on trends or rates of change in oxygen saturation, without the specific comparison to a lower limit and diminishing offset.

Patent timeline

Filing

Application submitted to the patent office

Publication

Application published, typically 18 months after filing

Grant

Patent officially issued

PatentBrief Score

Impact Score

Strong

Citation count

40/40

Highly cited

Claim breadth

14/20

Broad claimsclaimsThe numbered statements at the end of a patent that legally define what the inventor owns.Read more →

Recency

10/20

Granted 5–10 years ago

Assignee scale

0/20

Independent or smaller assigneeassigneeThe entity that owns the patent — usually the inventor's employer or a company.Read more →

PatentBrief Impact Score — based on citation count, claim breadth, recency, and assignee scale. Not a legal assessment.

Heuristic Value Estimate

What this patent might be worth

High value

$1.1M$3.4M

Midpoint $2.1M · 11.6 yr remaining · industry ×2.2

Adjust inputs →

Heuristic only — blends forward/backward citation counts, claim scope, time remaining, litigation history, and CPC-derived industry baseline. Real valuations need a professional appraisal.

The original legal language

Original claims

21 claims as filed with the patent office.

Concepts involved

ClaimPrior artNon-obviousnessNoveltySpecificationAssigneePatent term

Citations

Patent lineage

Cites earlier patents

852

earlier patents this invention cites as foundations

View prior art →

Cited by later patents

251

later patents that build on this invention

View patents →

Cite this patent

Al-Ali, A. (2019). How Medical Monitors Adapt Oxygen Alarms to Reduce False Alerts (U.S. Patent No. RE47,218). U.S. Patent and Trademark Office. https://patentbrief.org/patent/us/RE47218/tysabri-dosing

Auto-generated from the patent record. Double-check author order and the issue date against the official USPTO document before submitting.

Embed

Add this patent to your site

Drop this plain-English patent card into any blog post or article — free, no signup. It always links back to the full breakdown here.

<div data-patentlens-widget data-patent-number="USRE47218"></div>
<script src="https://patentbrief.org/embed.js" async></script>

Stay in the loop

Get a weekly digest of new patents.

One email per week. No spam. Unsubscribe anytime.

Keep exploring

Related patents you should know

US 4683195 · 1987

How to Make Billions of Copies of a DNA Segment

This patent describes the Polymerase Chain Reaction (PCR), a method to rapidly create many copies of a specific piece of DNA or RNA, enabling its detection and analysis.

Cetus Corp

US 8697359 · 2014

How to Edit Genes in Human Cells Using an Engineered CRISPR System

This patent describes an engineered CRISPR-Cas9 system for precisely cutting DNA in eukaryotic cells to change how genes work, opening the door for gene editing in complex organisms.

Massachusetts Institute of Technology

US 7657849 · 2010

How the iPhone's Slide-to-Unlock Gesture Works

Apple's 2010 patent describes unlocking a device by dragging a specific graphical image across the touchscreen along a predefined path, a gesture that became iconic with the original iPhone.

Apple Inc

US 4733665 · 1988

How Doctors Implant a Permanent Stent Using a Balloon

This patent describes the method for placing a permanent, expandable wire mesh tube inside a blood vessel or other body tube using a balloon-tipped catheter to widen it and keep it open.

Expandable Grafts Partnership

US 4965188 · 1990

How to Make Many Copies of a DNA Piece with Heat

This patent describes the Polymerase Chain Reaction (PCR) method, a technique to make millions of copies of a specific DNA segment using a heat-resistant enzyme and repeated temperature changes.

Cetus Corp

US 4235871 · 1980

How to Encapsulate Active Materials in Lipid Bubbles Efficiently

This patent describes a method for trapping biologically active substances inside tiny, multi-layered fat bubbles called liposomes, using a specific water-in-oil emulsion and gel-forming process to improve how much material gets captured.

Individual

More to explore

More in Biotech & Medicine

Browse all Biotech & Medicine

New to patents?

What is a patent?How to read a patentAnatomy of a claimHow strong is this patent?What the citations meanWhat it doesn't coverBiotech PatentsPatent glossary

Common Questions

Frequently Asked Questions

What does How Medical Monitors Adapt Oxygen Alarms to Reduce False Alerts cover?

This patent describes an adaptive alarm system for medical patient monitors that dynamically adjusts oxygen saturation thresholds based on recent patient data, aiming to reduce unnecessary alerts.

Who owns patent US RE47218?

Masimo Corp owns this patent, granted in 2019.

When does this patent expire?

This patent is expected to expire on February 5, 2039, when the invention enters the public domain.

What is patent US RE47218 cited by?

This patent has been cited by 251 later patents that build on its ideas.

What problem does this patent solve?

In hospitals, too many false alarms can lead to "alarm fatigue," where medical staff become desensitized to alerts, potentially missing real emergencies. This patent addresses this critical issue by making patient monitoring systems smarter and more responsive to individual patient conditions. By reducing unnecessary alarms, it helps ensure that healthcare providers focus on truly critical events, improving patient safety and staff efficiency.

What does this patent NOT cover?

Does not cover alarm systems that use fixed, unchanging thresholds for oxygen saturation, regardless of the patient's current stable levels.

Patent monitoring

Get notified when Masimo Corp files a new patent

Get notified when this company files a new patent. Weekly digest · Confirm via email · Unsubscribe anytime.

Last reviewed: June 15, 2026 · PatentBrief is not a law firm and this is not legal advice.